The nuclear lamina is a network of filaments that underlies the nuclear membrane and is made up of proteins called lamins. The nuclear lamina plays essential roles in nuclear architecture, positioning of nuclear pores, gene expression regulation, chromatin organization, DNA replication, and DNA repair1,2,3. Mutations in genes that play a role in the expression of the lamin proteins lead to genetic disorders called laminopathies3.
Restrictive dermopathy (RD) is a severe laminopathy disorder predominantly caused by compound heterozygous mutations that create premature termination codons in the ZMPSTE24 gene4, leading to an absence of the metalloprotease ZMPSTE24. This laminopathy is characterized by intrauterine growth retardation, tight, rigid skin, small-sized mouth, thin hair, and bone mineralization defects1. RD patients usually do not live past their first week of life due to pulmonary insufficiency1. Two other laminopathy disorders known as atypical Hutchinson-Gilford Progeria Syndrome (AT-HGPS) and Mandibuloacral dysplasia type B (MAD-B) involve reduced ZMPSTE24 expression and are associated with reduced lifespan and show similarities to premature aging disorders5. The ZMPSTE24 protease that is impacted in these laminopathies is vital in the post-translational modification of lamin A, which is a critical component of the nuclear lamina. ZMPSTE24 deficiency results in the accumulation of an incompletely processed farnesylated form of lamin A, known as prelamin A2.

Figure 1: Lamin A processing in normal vs. RD cells. Lamin A processing pathway in normal cells (left) and altered lamin A processing in RD, or ZMPSTE deficient cells (right). Farnesyl (Fa) and methyl (Me) groups are indicated. Please click here to view a larger version of this figure.
As seen in Figure 1, in normal lamin A processing, a farnesyl (lipid) group is attached to a cysteine residue near the C-terminus, followed by proteolytic cleavage of three C-terminal amino acids3,6. The cysteine residue is then methylated. These two modifications allow prelamin A to be targeted to the inner nuclear membrane2. ZMPSTE24 then carries out a cleavage reaction whereby the last 15 C-terminal amino acids, along with the farnesyl and methyl groups, are removed to produce mature Lamin A protein, which is delivered to the nuclear lamina6,7,8. In RD, AT-HGPS, and MAD-B, the final step of processing does not occur effectively since the ZMPSTE24 metalloproteinase is lacking or not fully functional8,9. This results in the accumulation of prelamin A, which remains permanently farnesylated and methylated9. These latter groups cause the prelamin A to stick to the inner nuclear membrane instead of localizing to the nuclear lamina, where mature lamin A should ultimately reside, as seen in Figure 1. Thus, ZMPSTE deficiency has profound effects on a variety of nuclear functions, along with nuclear structure10,11,12,13,14,15. These alterations to nuclear structure may include nuclear blebbing and even nuclear rupturing which can result in the leakage of DNA into the cytosol as well as ingress of cytosol into the nucleus. Aberrantly shaped nuclei are indeed a hallmark of laminopathy disorders, along with numerous other phenotypes that are caused by defective prelamin A processing16,17. Defects in the nuclear lamina lead to a multitude of detrimental impacts, including the mislocalization of nuclear protein quality control and DNA repair proteins in the nucleoplasm, which, in turn, results in numerous defects in nuclear function18. It is important to have a simple technique that can help to identify and monitor these hallmarks of laminopathies to facilitate research into the development of therapeutic approaches aimed at ameliorating laminopathy phenotypes. For mice with laminopathies, it has been shown that the elimination of nuclear blebbing correlates with the generalized elimination of laminopathy phenotypes16. A technique that allows monitoring of nuclear integrity in human cells could enhance the study of potential treatments for eliminating or significantly improving disease phenotypes.
Indirect immunofluorescence (IF) is a sensitive and widely used technique that uses both a primary unlabeled antibody and a fluorophore-labeled secondary antibody that recognizes the primary antibody to detect a target of interest19. IF methods can provide a powerful means for visualizing specific intracellular components and structures. It is also possible that more than one secondary antibody molecule may interact with the primary antibody, resulting in amplification of the signal19. Indirect IF is a versatile technique that also allows the detection of multiple primary antibodies with a relatively small set of secondary antibodies since secondary antibodies are raised against the Fc domain of the primary antibody, which is conserved within species19.
This article describes an indirect (IF) method to assess nuclear blebbing and DNA leakage in cells deficient in ZMPSTE24, using antibodies against double-stranded DNA (dsDNA) and lamin B1 to detect DNA and the nuclear lamina, respectively. To demonstrate the utility of this approach, the procedure was applied to a HeLa cell line with knocked-out ZMPSTE24 expression, as well as a HeLa cell line that expresses ZMPSTE24, and the outcomes for the two cell lines were compared.